Compound
Sermorelin
Everything in the archive that discusses Sermorelin in substance — with sources and context.
4 matching articles
Research · 5 September 2026 · 12 min read
Growth Hormone Secretagogues: One Approved Drug, Several Research Compounds, and the Difference
Tesamorelin is an FDA-approved medicine with phase 3 trial data. Ipamorelin and sermorelin are not approved for general use and rest on far thinner evidence. What separates a licensed GHRH analogue from an online 'GH peptide'.
Research · 31 August 2026 · 5 min read
Evaluating Mod GRF 1-29 (CJC-1295 Without DAC): Secretagogue Kinetics, Receptor Dynamics, and Experimental Limitations
An editorial review examining the short-acting GHRH analog Mod GRF 1-29 (CJC-1295 no DAC), its physiological mechanism, pulsatile release profiles, and comparative distinction from long-acting formulations.
Longevity · 31 August 2026 · 6 min read
Beyond the Celebrity Spotlight: A Scientific Evaluation of Peptide Signaling and Dermal Remodeling
A critical, evidence-first assessment of injectable, topical, and oral peptide modalities popularized in mainstream anti-aging discussions, evaluating their pharmacokinetic realities and cellular mechanisms.
Longevity · 31 August 2026 · 5 min read
Evaluating Sermorelin: Mechanistic Insights and Evidence in Somatotropic Axis Modulation
An editorial examination of Sermorelin acetate, analyzing its mechanism of action, pituitary feedback dynamics, and clinical evidence comparing GHRH secretagogues to direct growth hormone replacement.